Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Chalandon

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Bone Marrow Transplantation|February 9, 2016
Excellent outcome with a high proportion of mixed chimerism in patients with severe aplastic anemia treated with partially T-cell-depleted peripheral hematopoietic stem cell transplantsS Masouridi-Levrat, F Simonetta, Y Beauverd, et al.
Transplantation and Cellular Therapy|November 15, 2025
Late toxicity of allogeneic stem cell transplantation for Non-Hodgkin lymphoma patients. SBST based analysis 1997-2021 and review of literatureA von Werdt, A Künzi, A Haynes, et al.
British Journal of Haematology|May 21, 2025
Kaposi sarcoma and Kaposi inflammatory cytokine syndrome following allogeneic haematopoietic stem cell transplantation: A case reportE Laspa, D Neofytos, D Boutboul, et al.
Bone Marrow Transplantation|June 9, 2015
High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparitiesJ R Passweg, U Schanz, Y Chalandon, et al.
The Journal of Hospital Infection|June 30, 2024
Impact of intermittent versus continuous infusions on central line-associated bloodstream infection risk in haemato-oncology patients: a quasi-experimental studyA MacPhail, A Nguyen, V Camus, et al.
Cancer Chemotherapy and Pharmacology|October 10, 2014
Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trialV Gotta, N Widmer, L A Decosterd, et al.
Bone Marrow Transplantation|March 10, 2015
Second allo-SCT in patients with lymphoma relapse after a first allogeneic transplantation. A retrospective study of the EBMT Lymphoma Working PartyK Horstmann, A Boumendil, J Finke, et al.
Bone Marrow Transplantation|March 28, 2006
Impact of high-resolution matching in allogeneic unrelated donor stem cell transplantation in SwitzerlandY Chalandon, J-M Tiercy, U Schanz, et al.
Bone Marrow Transplantation|September 17, 2013
The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCTA Marek, M Stern, Y Chalandon, et al.
Microbiome|January 25, 2021
Unmasking viral sequences by metagenomic next-generation sequencing in adult human blood samples during steroid-refractory/dependent graft-versus-host diseaseM C Zanella, S Cordey, F Laubscher, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Bone Marrow Transplantation|February 9, 2016
Excellent outcome with a high proportion of mixed chimerism in patients with severe aplastic anemia treated with partially T-cell-depleted peripheral hematopoietic stem cell transplantsS Masouridi-Levrat, F Simonetta, Y Beauverd, et al.
Transplantation and Cellular Therapy|November 15, 2025
Late toxicity of allogeneic stem cell transplantation for Non-Hodgkin lymphoma patients. SBST based analysis 1997-2021 and review of literatureA von Werdt, A Künzi, A Haynes, et al.
British Journal of Haematology|May 21, 2025
Kaposi sarcoma and Kaposi inflammatory cytokine syndrome following allogeneic haematopoietic stem cell transplantation: A case reportE Laspa, D Neofytos, D Boutboul, et al.
Bone Marrow Transplantation|June 9, 2015
High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparitiesJ R Passweg, U Schanz, Y Chalandon, et al.
The Journal of Hospital Infection|June 30, 2024
Impact of intermittent versus continuous infusions on central line-associated bloodstream infection risk in haemato-oncology patients: a quasi-experimental studyA MacPhail, A Nguyen, V Camus, et al.
Cancer Chemotherapy and Pharmacology|October 10, 2014
Clinical usefulness of therapeutic concentration monitoring for imatinib dosage individualization: results from a randomized controlled trialV Gotta, N Widmer, L A Decosterd, et al.
Bone Marrow Transplantation|March 10, 2015
Second allo-SCT in patients with lymphoma relapse after a first allogeneic transplantation. A retrospective study of the EBMT Lymphoma Working PartyK Horstmann, A Boumendil, J Finke, et al.
Bone Marrow Transplantation|March 28, 2006
Impact of high-resolution matching in allogeneic unrelated donor stem cell transplantation in SwitzerlandY Chalandon, J-M Tiercy, U Schanz, et al.
Bone Marrow Transplantation|September 17, 2013
The impact of T-cell depletion techniques on the outcome after haploidentical hematopoietic SCTA Marek, M Stern, Y Chalandon, et al.
Microbiome|January 25, 2021
Unmasking viral sequences by metagenomic next-generation sequencing in adult human blood samples during steroid-refractory/dependent graft-versus-host diseaseM C Zanella, S Cordey, F Laubscher, et al.
Pageof 6